INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
Our Lives in Whose Hands? The Lifecycle of an Experimental Biological Medicine—Hedley Rees

Our Lives in Whose Hands? The Lifecycle of an Experimental Biological Medicine—Hedley Rees

Please take a listen...

Hedley Rees's avatar
Hedley Rees
Feb 03, 2023
∙ Paid
19

Share this post

INSIDE PHARMA
INSIDE PHARMA
Our Lives in Whose Hands? The Lifecycle of an Experimental Biological Medicine—Hedley Rees
2
Share

UK Column Interview:

Our Lives in Whose Hands? The Lifecycle of an Experimental Biological Medicine—Hedley Rees

UK Column account:

Discussion of this interview, and updates since it was recorded, were given at 6:26 onwards in the UK Column News episode of 25 January 2023.

The United Kingdom is deemed to have a prestigious life sciences history to be proud of. In the late eighteenth century, Edward Jenner developed the first ‘vaccine’ for smallpox. Ranked fourth in the Global Innovation Index, the UK is seen to play a vital role in global science endeavours and is marketed as a superpower in life sciences.

As such, many would be forgiven for thinking that His Majesty’s Government has its own population’s best interests as a priority in the engineering and marketing of medicines. They would be wrong. Without the central involvement of the UK Government, the British medicines regulator MHRA, the UK Health Security Agency (UKHSA) et al., would the worldwide Covid agenda would hardly have been …

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share